Datasets
Buyer room
EICHOR.COMManage supplier listing
Eichor (Biomedistats LLC, d/b/a Eichor) — Daily-reconciled clinical-trial registry change intelligence: site-level risk scores (A–F), 0–100 trial distress scores, enrollment velocity, results-disclosure compliance status (FDAAA 801 / EU CTIS Art.37 / UK ISRCTN), investigator and site dossiers, and a tamper-evident signed ledger of day-of-change registry events built from ClinicalTrials.gov, EU CTIS, UK ISRCTN/MHRA, FDA, SEC EDGAR, NIH RePORTER and CMS.. Micro-cap private specialist (single US LLC trading as Eichor); self-serve $199/mo monitors, $999/seat/mo Signals, $995/$1,995/$4,995 report …
supplier index read from their site
Daily-reconciled clinical-trial registry change intelligence: site-level risk scores (A–F), 0–100 trial distress scores, enrollment velocity, results-disclosure compliance status (FDAAA 801 / EU CTIS Art.37 / UK ISRCTN), investigator and site dossiers, and a tamper-evident signed ledger of day-of-change registry events built from ClinicalTrials.gov, EU CTIS, UK ISRCTN/MHRA, FDA, SEC EDGAR, NIH RePORTER and CMS.
From 3 yearsCoverage Health Care · Information TechnologyAsset class Equities
Sample, licence terms, pricing and eval results when Eichor publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Eichor, answered from this page.
Eichor (Biomedistats LLC, d/b/a Eichor) — Daily-reconciled clinical-trial registry change intelligence: site-level risk scores (A–F), 0–100 trial distress scores, enrollment velocity, results-disclosure compliance status (FDAAA 801 / EU CTIS Art.37 / UK ISRCTN), investigator and site dossiers, and a tamper-evident signed ledger of day-of-change registry events built from ClinicalTrials.gov, EU CTIS, UK ISRCTN/MHRA, FDA, SEC EDGAR, NIH RePORTER and CMS.. Micro-cap private specialist (single US LLC trading as Eichor); self-serve $199/mo monitors, $999/seat/mo Signals, $995/$1,995/$4,995 report …
Eichor offers (Alternative, Fundamental) — Full public registry corpus (~550K+ registered studies across CT.gov, CTIS, ISRCTN) re-scanned daily, plus >3,000 indexed drugs, per-site landscapes for every scanned trial, and a maintained FDAAA view currently flagging 1,323 overdue trials with ~15 new additions per week; the licensable asset is the accumulated day-of-change event log.
Alternative data for biotech/pharma equity and event-driven investment research (trial distress and disclosure breach as catalyst signals); sponsor site selection and feasibility; CRO/CDMO/central-lab business-development targeting from new Phase 2/3 registrations; portfolio R&D execution risk scoring; research-integrity and compliance monitoring for academic institutions
The data is with 3 years of history.
Coverage spans US, UK; Health Care Technology, Application Software; alternative, fundamental; equities.
Eichor has not added their own details yet. Not yet on file: